ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Oppenheimer's 27th Annual Healthcare Conference was March 21-22, 2017. Since Ani attended the last three of their conferences, in all likelihood they attended this one as well. They have always posted the conference presentation webcast on the Ani website for both Roth and Oppenheimer conferences.

Oppenheimer Conference

Personally, I think they will make an announcement just before the patent applications get published. This is when new specifications submitted to support the claim that restoring T-Levels reduces the number of Breast Cancer events will be made public. Their could also be additional data in the specifications supporting the change from reducing the risk of CV events to reducing the number of CV events.

I suspect it will confirm additional analysis and should expose the existence of a Libigel Partner. Abbvie is still the lead contender and if my findings,though circumstantial, are accurate, Dr Snabes will most likely be leading a global study on their behalf.

JMHO